Entry |
|
Name |
Rifamycins |
Class |
|
Pathway map |
|
Compound |
D00424 | Rifabutin (JAN/USP/INN) |
D02554 | Rifaximin (JAN/USAN/INN) |
D08480 | Rifamycin sodium (USAN) |
|
Reference |
|
Authors |
Fukai S. |
Title |
[New Drugs Today (6th ed)] (In Japanese) |
Journal |
Jiho (1995) |
Reference |
|
Authors |
David AW, Thomas LL, William OF. |
Title |
Foye's Principles of Medicinal Chemistry (5th ed) |
Journal |
Lippincott Williams & Wilkins (2002) |
Reference |
|
Authors |
Hardman JG, Limbird LE, Gilman AG (eds). |
Title |
Goodman & Gilman's The Pharmacological Basis of Therapeutics (10th ed) |
Journal |
McGraw-Hill (2001) |
Reference |
|
Authors |
Walter S. |
Title |
Drug Discovery: A History |
Journal |
Wiley (2005) |
Reference |
|
Authors |
Saito H, Tomioka H, Sato K, Emori M, Yamane T, Yamashita K, Hosoe K, Hidaka T |
Title |
In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins. |
Journal |
|
Reference |
|
Authors |
Heifets L, Sanchez T, Vanderkolk J, Pham V |
Title |
Development of rifapentine susceptibility tests for Mycobacterium tuberculosis. |
Journal |
|
Reference |
|
Authors |
Floss HG, Yu TW. |
Title |
Rifamycin-mode of action, resistance, and biosynthesis. |
Journal |
|
Related pathway |
|
LinkDB |
|